{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:58:24Z","timestamp":1781179104110,"version":"3.54.1"},"reference-count":51,"publisher":"Scientific Scholar","issue":"04","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":136,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accounting for 8.7% of global cancer deaths, colorectal cancer (CRC) is one of the leading causes of cancer-related mortality. Cytoreduction surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is part of a multimodal strategy for managing CRC. HIPEC is designed to target residual microscopic disease using heated chemotherapy. There are several techniques including the open abdomen \u201ccoliseum\u201d technique, which uses a silastic sheet to create a perfusion chamber and allows for manipulation of contents; whereas the closed abdomen technique maintains a sterile environment and may involve abdominal wall massage for heat distribution; lastly, the laparoscopic method combines the benefits of both techniques with enhanced drug distribution through laparoscopy. Research has shown that the coliseum technique offers superior heat uniformity, while the laparoscopic method provides optimal distribution with advanced monitoring tools. We examined early trials, procedural variations, and recent clinical research to assess its efficacy.<\/jats:p>\n                  <jats:p>HIPEC involves the administration of heated chemotherapy directly into the peritoneal cavity after CRS in order to enhance local tumor control and survival. Various regimens that have been explored, including the Sugarbaker, triple dosing, and low dose mitomycin C regimen, report mixed results. The selection of chemotherapy drugs and their efficacy at high temperatures is crucial, with studies yielding mixed results for oxaliplatin and mitomycin C. The advantages of HIPEC, especially with oxaliplatin-based regimens, have been questioned by recent trials such as the PRODIGE 7 study because of problems like chemoresistance and greater postoperative morbidity. On the other hand, HIPEC is still supported by some as a good choice for individuals who are carefully chosen, particularly when combined with other forms of treatment. Despite being widely used in several cancer centers around the world for other pathologies, HIPEC remains a debated treatment option in CRC with peritoneal metastases. Even though the current evidence suggests that it might not provide a statistically meaningful overall survival improvement when compared to CRS alone, it might still be useful in some clinical settings or when combined with well-designed protocols. Thus, the necessity of more research and standardized protocols is paramount.<\/jats:p>\n                  <jats:p>Determining the role of HIPEC, maximizing patient selection, and contrasting its effectiveness with other intraperitoneal treatments such as pressurized intraperitoneal aerosol chemotherapy and early postoperative intraperitoneal chemotherapy will require ongoing trials and future research. Until clearer evidence emerges, HIPEC should be considered a therapeutic option for selected patients and offered by dedicated, experienced centers and surgical teams.<\/jats:p>","DOI":"10.1055\/s-0045-1802982","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T19:13:51Z","timestamp":1739560431000},"page":"267-273","source":"Crossref","is-referenced-by-count":1,"title":["Current Status of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer (CRC)"],"prefix":"10.25259","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-1625","authenticated-orcid":false,"given":"S.P.","family":"Somashekhar","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Aster DM Healthcare, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9659-7355","authenticated-orcid":false,"given":"Adwaith Krishna","family":"Surendran","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, BLK-Max Super Speciality Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumitra","family":"Rawat","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, Sir Ganga Ram Hospital (SGRH), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Selvasekar","sequence":"additional","affiliation":[{"name":"Clinical Services & Specialist Surgery, The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvish M.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, Sri Ram Cancer Center, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"ref2","volume-title":"Hyperthermic Intraperitoneal Chemotherapy","author":"M Ben Aziz","year":"2024"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","article-title":"Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials","volume":"40","author":"F Coccolini","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"ref6","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"V J Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"D Elias","year":"2009","journal-title":"J Clin Oncol"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"D Go\u00e9r\u00e9","year":"2013","journal-title":"Ann Surg"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/pp-2017-0003","article-title":"Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice","volume":"2","author":"K Van der Speeten","year":"2017","journal-title":"Pleura Peritoneum"},{"issue":"01","key":"ref10","first-page":"143","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future","volume":"7","author":"A Dehal","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","article-title":"Hyperthermic intraperitoneal chemotherapy: rationale and technique","volume":"2","author":"S Gonz\u00e1lez-Moreno","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1096-9098(200005)74:1<41::AID-JSO10>3.0.CO;2-R","article-title":"Treatment of peritoneal carcinomatosis with intent to cure","volume":"74","author":"F Cavaliere","year":"2000","journal-title":"J Surg Oncol"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF02409050","article-title":"Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases","volume":"3","author":"S Schneebaum","year":"1996","journal-title":"Ann Surg Oncol"},{"issue":"16","key":"ref15","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study","volume":"22","author":"O Glehen","year":"2004","journal-title":"J Clin Oncol"},{"issue":"09","key":"ref16","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"V J Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/ija.IJA_765_19","article-title":"Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)","volume":"63","author":"S L Solanki","year":"2019","journal-title":"Indian J Anaesth"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21061","article-title":"Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion","volume":"98","author":"O Glehen","year":"2008","journal-title":"J Surg Oncol"},{"issue":"05","key":"ref19","first-page":"431","article-title":"Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection","volume":"1","author":"D Elias","year":"2000","journal-title":"Int J Surg Investig"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0972-9941.158965","article-title":"Laparoscopic HIPEC: a bridge between open and closed-techniques","volume":"12","author":"M Lotti","year":"2016","journal-title":"J Minim Access Surg"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"BSR20180322","DOI":"10.1042\/BSR20180322","article-title":"Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients","volume":"38","author":"Y C Yang","year":"2018","journal-title":"Biosci Rep"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1158\/1078-0432.CCR-15-0297","article-title":"Circulating DNA as a strong multimarker prognostic tool for metastatic colorectal cancer patient management care","volume":"22","author":"S El Messaoudi","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"e003312","DOI":"10.1136\/jitc-2021-003312","article-title":"Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer","volume":"10","author":"P M Kasi","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jamaoncol.2018.5080","article-title":"Rechallenge for patients with RAS and BRAF wild-type metastatic colorectal cancer with acquired resistance to first-line cetuximab and irinotecan: a phase 2 single-arm clinical trial","volume":"5","author":"C Cremolini","year":"2019","journal-title":"JAMA Oncol"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13046-022-02318-0","article-title":"Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer","volume":"41","author":"A Raza","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"590452","DOI":"10.3389\/fsurg.2020.590452","article-title":"Clinical efficacy and safety of hyperthermic intraperitoneal chemotherapy in colorectal cancer patients at high risk of peritoneal carcinomatosis: a systematic review and meta-analysis","volume":"7","author":"P Y Zhao","year":"2020","journal-title":"Front Surg"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/jcm7120567","article-title":"Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer","volume":"7","author":"C Yurttas","year":"2018","journal-title":"J Clin Med"},{"issue":"05","key":"ref29","first-page":"1249","article-title":"Primary curative surgery and preemptive or adjuvant hyperthermic peritoneal chemotherapy in colorectal cancer patients at high risk to develop peritoneal carcinomatosis. A systematic review","volume":"23","author":"K Stamou","year":"2018","journal-title":"J Balkan Union Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/ans.19021","article-title":"A systematic review of minimally invasive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal malignancy","volume":"94","author":"L Cohen","year":"2024","journal-title":"ANZ J Surg"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00384-020-03702-y","article-title":"Oxaliplatin versus mitomycin C in HIPEC for peritoneal metastasis from colorectal cancer: a systematic review and meta-analysis of comparative studies","volume":"35","author":"X Zhang","year":"2020","journal-title":"Int J Colorectal Dis"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jso.23546","article-title":"The use of oxaliplatin or mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study","volume":"109","author":"D Hompes","year":"2014","journal-title":"J Surg Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.critrevonc.2019.06.014","article-title":"Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer","volume":"142","author":"D D Wisselink","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"18","key":"ref34","doi-asserted-by":"crossref","first-page":"LBA3503","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","article-title":"A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7","volume":"36","author":"F Quenet","year":"2018","journal-title":"JCO"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"F Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"01","key":"ref36","first-page":"45","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus R0 resection for resectable colorectal cancer with peritoneal metastases and low peritoneal cancer index scores: a collaborative observational study from Korea and Japan","volume":"110","author":"D Kitaguchi","year":"2024","journal-title":"Int J Surg"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejso.2021.10.008","article-title":"The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: a systematic review and meta-analysis","volume":"48","author":"A Di Giorgio","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00384-021-04021-6","article-title":"Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis","volume":"37","author":"M Lundbech","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/nu13020482","article-title":"Cancer related anemia: an integrated multitarget approach and lifestyle interventions","volume":"13","author":"V Natalucci","year":"2021","journal-title":"Nutrients"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s13193-016-0504-6","article-title":"Complications of cytoreductive surgery and HIPEC in the treatment of peritoneal metastases","volume":"7","author":"S S Mehta","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1245\/s10434-022-11699-7","article-title":"The impact of neoadjuvant chemotherapy on the surgical management of colorectal peritoneal metastases: a systematic review and meta-analysis","volume":"29","author":"M P Flood","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ctrv.2012.11.003","article-title":"Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies","volume":"39","author":"E MV de Cuba","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"08","key":"ref43","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1245\/s10434-009-0487-4","article-title":"A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin","volume":"16","author":"C Cao","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/codi.15003","article-title":"Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis","volume":"22","author":"V Narasimhan","year":"2020","journal-title":"Colorectal Dis"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","article-title":"Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"3","author":"S Hallam","year":"2019","journal-title":"BJS Open"},{"issue":"06","key":"ref46","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/cancers16061182","article-title":"Systemic chemotherapy in colorectal peritoneal metastases treated with cytoreductive surgery: systematic review and meta-analysis","volume":"16","author":"M Tonello","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/DCR.0000000000002027","article-title":"Synchronous liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: a systematic review and meta-analysis","volume":"64","author":"M P Flood","year":"2021","journal-title":"Dis Colon Rectum"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/DCR.0000000000002315","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review","volume":"65","author":"M S Parikh","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"ref49","first-page":"1328","article-title":"Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for the prevention and control of peritoneal metastasis in patients with gastrointestinal malignancies: a systematic review of randomized controlled trials","volume":"20","author":"J L Dominic","year":"2021","journal-title":"EXCLI J"},{"issue":"06","key":"ref50","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/wjs.12186","article-title":"Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: a systematic review of randomized controlled trials","volume":"48","author":"K Gurusamy","year":"2024","journal-title":"World J Surg"},{"issue":"09","key":"ref51","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"D Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"C EL Klaver","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"zraa075","DOI":"10.1093\/bjsopen\/zraa075","article-title":"Effect of oxaliplatin-based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof-of-concept study","volume":"5","author":"A Prabhu","year":"2021","journal-title":"BJS Open"},{"issue":"05","key":"ref54","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10147-015-0816-5","article-title":"Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists","volume":"20","author":"H J Braam","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/cancers15010165","article-title":"Colorectal cancer with peritoneal metastases: the impact of the results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 trials on peritoneal disease management","volume":"15","author":"A Sommariva","year":"2022","journal-title":"Cancers (Basel)"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"S680","DOI":"10.1016\/j.annonc.2022.07.452","article-title":"314O Adjuvant hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): a randomized phase III study","volume":"33","author":"A Arjona-Sanchez","year":"2022","journal-title":"Ann Oncol"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1802982.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:59Z","timestamp":1781176379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/current-status-of-hyperthermic-intraperitoneal-chemotherapy-hipec-in-colorectal-cancer-crc\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":51,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,3,7]]},"published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0045-1802982","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}